NCT04449458 The Positively Quit Trial for Smoking Cessation
| NCT ID | NCT04449458 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of South Florida |
| Condition | Cigarette Smoking |
| Study Type | INTERVENTIONAL |
| Enrollment | 482 participants |
| Start Date | 2020-06-10 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 482 participants in total. It began in 2020-06-10 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main goal of the present study is to determine if a smoking cessation program designed for people living with certain chronic conditions and delivered via videoconferencing groups works better than a control condition--a program that is not designed to help with smoking but that does have the same number of group contact hours as the other program (this program is called the Attention Matched Control condition; AMC) for helping people with certain health conditions stop smoking. People in both groups will receive brief advice to quit and an offer of nicotine replacement therapy patches (NRT), as well as 12 videoconferencing group sessions. The team will measure smoking behavior over a one-year period and compare smoking rates for the treatment condition against AMC to see if the treatment condition is better at getting people living with certain health conditions to quit smoking.
Eligibility Criteria
Inclusion Criteria: * greater than or equal to age 18 (as NRT is not FDA approved for adolescents) * self-report smoking cigarettes * positive cotinine test * motivated to quit * own a smart phone, laptop, desktop, or tablet computer * able to join group from a private space with Internet access * demonstrate the ability to connect to the HIPAA-compliant videoconferencing system, Zoom, over the internet h) speak English i) living in the US j) living with certain health conditions Exclusion Criteria: * pregnant, breastfeeding, or have other contraindications to NRT * receiving other tobacco treatment, or * inability to communicate coherently in English during the video-conferencing test or other pre-enrollment interactions
Contact & Investigator
Stephanie L Marhefka, PhD
PRINCIPAL INVESTIGATOR
University of South Florida
Frequently Asked Questions
Who can join the NCT04449458 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cigarette Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04449458 currently recruiting?
Yes, NCT04449458 is actively recruiting participants. Contact the research team at catherynf@usf.edu for enrollment information.
Where is the NCT04449458 trial being conducted?
This trial is being conducted at Tampa, United States.
Who is sponsoring the NCT04449458 clinical trial?
NCT04449458 is sponsored by University of South Florida. The principal investigator is Stephanie L Marhefka, PhD at University of South Florida. The trial plans to enroll 482 participants.